About us

Out of complexity we create precision

Owkin is an AI Biotech that uses AI to unlock complex biology to find the right treatment for every patient
Get in touch

Our story

Transforming drug discovery and development

Owkin was founded by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, PhD, a pioneer in the field of machine learning in biology, in 2016.

We use AI to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes.

Owkin at a glance

A diverse multidisciplinary team

350
Team
67
PhDs
23
Languages
39
/
61
Female/male*

Our multidisciplinary team have expertise across machine learning, statistics, medicine, and biology.

*For the year 2022, Owkin’s score for the “Professional Equality Index” in France, is 93/100. This index measure wage equality between women and men within the company.
Careers at Owkin

Owkin values

1/4
Collaboration

We work better together

2/4
Care

We put others at the center

3/4
Curiosity

We always ask "why?"

4/4
Creativity

We dare to try new ideas

Close
Button